Sentence examples for aims to develop novel from inspiring English sources
This group also aims to develop novel approaches to sustainable development and to complement the work of the HLP with technical support.
The present paper aims to develop novel, feasible, practical methods for power spectrum optimization.
This work aims to develop novel techniques, including low energy end-hall ion (EDH) source, nitrogen and silicon doping, to enhance the adhesion strength of Diamond-like carbon (DLC) on Polyethylene Terephthalate (PET) to address their major application issues.
The EU FP7-funded HiPerCap project aims to develop novel post-combustion CO2 capture technologies and processes which are environmentally benign and have high potential to lead to breakthroughs in energy consumption and overall cost.
The since 2010 running research program 'Bio-Based Geo & Civil Engineering for a Sustainable Society (BioGeoCivil)', funded by the Dutch technology foundation STW, aims to develop novel bio-based construction materials that can be used in Civil- and Geo-engineering constructions to enhance the sustainability performance of the sector.
PDXs constitute one such model that is widely used in preclinical research [ 8], and OncoTrack, the largest European public-private biomarker consortium which aims to develop novel biomarkers for targeted therapy [ 9], generated PDXs that were included here as an additional tumour type and an example of a common cancer (colon cancer (CC)).
This study aimed to develop novel FCS with multiple biofunctions as toothpaste additives.
This present study was aimed to develop novel and inexpensive NPs which have anticancer activity to cancer cell in vitro as well as serve as a drug carrier.
The present study was aimed to develop novel antibiofilm agents against two Gram-positive bacteria; Staphylococcus aureus (ATCC 43300) and Streptococcus mutans (ATCC 25175) using gold nanomaterials conjugated with 3- diphenylphosphino propionic acid (Au-LPa).
In December, The Fred Hutchinson Cancer Research Center, Memorial Sloan Kettering Cancer Center, along with pediatric partner Seattle Children's Research Institute teamed up to form Juno Therapeutics, a Seattle-based biotechnology company aiming to develop novel cancer immunotherapies.
Building upon the process of whole organ perfusion decellularization, we aimed to develop novel, translational methods for the recellularization and regeneration of transplantable lung constructs.
